| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 75.055 | 71.602 | 69.512 | 90.284 | 101.357 | 106.194 | 96.038 | 101.026 | 104.254 | 109.183 |
| Total Income - EUR | 81.577 | 76.663 | 70.578 | 90.811 | 103.246 | 107.156 | 96.317 | 102.906 | 105.603 | 109.297 |
| Total Expenses - EUR | 28.799 | 27.621 | 28.474 | 23.188 | 17.455 | 19.252 | 27.274 | 48.522 | 40.088 | 51.308 |
| Gross Profit/Loss - EUR | 52.777 | 49.042 | 42.104 | 67.623 | 85.791 | 87.904 | 69.043 | 54.383 | 65.515 | 57.989 |
| Net Profit/Loss - EUR | 50.874 | 47.590 | 41.409 | 66.720 | 84.763 | 86.892 | 68.197 | 53.561 | 64.525 | 55.759 |
| Employees | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cygnus Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.702 | 7.122 | 1.643 | 1.971 | 48.438 | 183.808 | 223.452 | 207.356 | 190.046 | 172.961 |
| Current Assets | 135.679 | 195.513 | 66.074 | 85.305 | 60.083 | 17.219 | 67.377 | 100.543 | 117.871 | 9.105 |
| Inventories | 2.067 | 2.068 | 2.033 | 2.240 | 2.196 | 0 | 0 | 142 | 142 | 1.141 |
| Receivables | 2.376 | 1.873 | 1.865 | 1.317 | 1.346 | 2.838 | 6.263 | 6.216 | 11.440 | 5.910 |
| Cash | 131.236 | 191.571 | 62.176 | 81.749 | 56.541 | 14.381 | 61.114 | 94.184 | 106.289 | 2.054 |
| Shareholders Funds | 150.613 | 196.667 | 56.461 | 84.143 | 100.730 | 185.712 | 249.791 | 304.127 | 307.080 | 176.172 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.962 | 5.967 | 11.256 | 3.133 | 7.791 | 15.424 | 41.497 | 4.143 | 1.136 | 5.481 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 668 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Cygnus Med S.r.l.